Skip to main content
Log in

The significance of tubulointerstitial lesions in childhood Henoch–Schönlein nephritis

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

Little information is currently available on the development of tubulointerstitial lesions in children with Henoch–Schönlein nephritis (HSN). To identify the impact of the development of tubulointerstitial changes in HSN, we retrospectively analyzed renal biopsies obtained from children with HSN.

Methods

Twenty-eight children with HSN from whom serial renal biopsies had been obtained before and after immunosuppressive therapy were enrolled in the study. The patients were divided into two groups according to the observed change in tubulointerstitial lesion development: group I (n = 15), with stable or improved tubulointerstitial lesions, and group II (n = 13), with worsened tubulointerstitial lesions. Group II patients had longer duration of proteinuria than group I patients (3.7 ± 3.7 years vs. 1.7 ± 1.7 years, p = 0.052).

Results

The change in serum albumin level was negatively correlated with the change in tubulointerstitial scores before and after treatment (γ = −0.444, p = 0.018). Group II patients showed a significant decrease in immunoglobulin G (IgG) and IgA deposits after treatment (p = 0.039 and 0.003, respectively), while group II patients did not (p = 0.458 and 0.506, respectively).

Conclusions

Although the International Study of Kidney Disease in Children classification of HSN does not include tubulointerstitial lesions, they can progress during treatment and could have significant clinical implications in association with the duration of proteinuria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, McCluskey RT, SinicoRA RAJ, Van Es LA, Waldheer R, Wiik A (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187–192

    Article  CAS  PubMed  Google Scholar 

  2. Counahan R, Winterborn MH, White RH, Heaton JM, Meadow SR, Bluett NH, Swetschin H, Cameron JS, Chantler C (1977) Prognosis of Henoch-Schönlein nephritis in children. Br Med J 2:11–14

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Goldstein AR, White RH, Akuse R, Chantler C (1992) Long-term follow-up of childhood Henoch-Schönlein nephritis. Lancet 339:280–282

    Article  CAS  PubMed  Google Scholar 

  4. Ronkainen J, Nuutinen M, Koskimies O (2002) The adult kidney 24 years after childhood Henoch-Schönlein purpura: a retrospective cohort study. Lancet 360:666–670

    Article  PubMed  Google Scholar 

  5. Ronkainen J, Ala-Houhala M, Huttunen NP, Jahnukainen T, Koskimies O, Ormala T, Nuutinen M (2003) Outcome of Henoch-Schoenlein nephritis with nephrotic-range proteinuria. Clin Nephrol 60:80–84

    Article  CAS  PubMed  Google Scholar 

  6. Wehrmann M, Bohle A, Held H, Schumm G, Kendziorra H, Pressler H (1990) Long-term prognosis of focal sclerosing glomerulonephritis. An analysis of 250 cases with particular regard to tubulointerstitial changes. Clin Nephrol 33:115–122

    CAS  PubMed  Google Scholar 

  7. Bohle A, Wehrmann M, Bogenschutz O, Batz C, Muller CA, Muller GA (1991) The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis. Pathol Res Pract 187:251–259

    Article  CAS  PubMed  Google Scholar 

  8. Schmitt H, Bohle A, Reineke T, Mayer-Eichberger D, Vogl W (1990) Long-term prognosis of membranoproliferative glomerulonephritis type I. Significance of clinical and morphological parameters: an investigation of 220 cases. Nephron 55:242–250

    Article  CAS  PubMed  Google Scholar 

  9. Bogenschutz O, Bohle A, Batz C, Wehrmann M, Pressler H, Kendziorra H, Gartner HV (1990) IgA nephritis: on the importance of morphological and clinical parameters in the long-term prognosis of 239 patients. Am J Nephrol 10:137–147

    Article  CAS  PubMed  Google Scholar 

  10. Foster BJ, Bernard C, Drummond KN, Sharma AK (2000) Effective therapy for severe Henoch-Schönlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. J Pediatr 136:370–375

    Article  CAS  PubMed  Google Scholar 

  11. Shin JI, Park JM, Kim JH, Lee JS, Jeong HJ (2006) Factors affecting histological regression of crescentic Henoch-Schönlein nephritis in children. Pediatr Nephrol 21:54–59

    Article  PubMed  Google Scholar 

  12. Shin JI, Park JM, Shin YH, Lee JS, Jeong HJ (2005) Role of mesangial fibrinogen deposition in the pathogenesis of crescentic Henoch-Schönlein nephritis in children. J Clin Pathol 58:1147–1151

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Shin JI, Park JM, Shin YH, Kim JH, Lee JS, Jeong HJ (2005) Henoch-Schönlein purpura nephritis with nephrotic-range proteinuria: histological regression possibly associated with cyclosporin A and steroid treatment. Scand J Rheumatol 34:392–395

    Article  CAS  PubMed  Google Scholar 

  14. Shin JI, Park JM, Shin YH, Kim JH, Kim PK, Lee JS, Jeong HJ (2005) Cyclosporin A therapy for severe Henoch-Schönlein nephritis with nephrotic syndrome. Pediatr Nephrol 20:1093–1097

    Article  PubMed  Google Scholar 

  15. Shin JI, Park JM, Shin YH, Lee JS, Jeong HJ, Kim HS (2005) Serum IgA/C3 ratio may be a useful marker of disease activity in severe Henoch-Schönlein nephritis. Nephron Clin Pract 101:c72–78

    Article  CAS  PubMed  Google Scholar 

  16. Shin JI, Park JM, Shin YH, Kim JH, Lee JS, Kim PK, Jeong HJ (2005) Can azathioprine and steroids alter the progression of severe Henoch-Schönlein nephritis in children? Pediatr Nephrol 20:1087–1092

    Article  PubMed  Google Scholar 

  17. Andoh TF, Bennett WM (1998) Chronic cyclosporine nephrotoxicity. Curr Opin Nephrol Hypertens 7:265–270

    Article  CAS  PubMed  Google Scholar 

  18. Meadow SR, Glasgow EF, White RH, Moncrieff MW, Cameron JS, Ogg CS (1972) Schönlein-Henoch nephritis. Q J Med 41:241–258

    CAS  PubMed  Google Scholar 

  19. Kawasaki Y, Suyama K, Hashimoto K, Hosoya M (2011) Methylprednisolone pulse plus mizoribine in children with Henoch-Schoenlein purpura nephritis. Clin Rheumatol 30:529–535

    Article  PubMed  Google Scholar 

  20. Daniel L, Saingra Y, Giorgi R, Bouvier C, Pellissier JF, Berland Y (2000) Tubular lesions determine prognosis of IgA nephropathy. Am J Kidney Dis 35:13–20

    Article  CAS  PubMed  Google Scholar 

  21. Koyama A, Igarashi M, Kobayashi M (1997) Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases. Am J Kidney Dis 29:526–532

    Article  CAS  PubMed  Google Scholar 

  22. Meng XM, Tang PM, Li J, Lan HY (2015) TGF-beta/Smad signaling in renal fibrosis. Front Physiol 6:82

    Article  PubMed  PubMed Central  Google Scholar 

  23. Kawasaki Y, Suzuki J, Sakai N, Nemoto K, Nozawa R, Suzuki S, Suzuki H (2003) Clinical and pathological features of children with Henoch-Schoenlein purpura nephritis: risk factors associated with poor prognosis. Clin Nephrol 60:153–160

    Article  CAS  PubMed  Google Scholar 

  24. Eddy AA, Kim H, Lopez-Guisa J, Oda T, Soloway PD (2000) Interstitial fibrosis in mice with overload proteinuria: deficiency of TIMP-1 is not protective. Kidney Int 58:618–628

    Article  CAS  PubMed  Google Scholar 

  25. Franceschini N, Alpers CE, Bennett WM, Andoh TF (1998) Cyclosporine arteriolopathy: effects of drug withdrawal. Am J Kidney Dis 32:247–253

    Article  CAS  PubMed  Google Scholar 

  26. Hamahira K, Iijima K, Tanaka R, Nakamura H, Yoshikawa N (2001) Recovery from cyclosporine-associated arteriolopathy in childhood nephrotic syndrome. Pediatr Nephrol 16:723–727

    Article  CAS  PubMed  Google Scholar 

  27. Ronkainen J, Autio-Harmainen H, Nuutinen M (2003) Cyclosporin A for the treatment of severe Henoch-Schönlein glomerulonephritis. Pediatr Nephrol 18:1138–1142

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ji Hong Kim.

Ethics declarations

This study was approved by the institutional review board (IRB) and the research ethics committee of Yonsei University Gangnam Severance Hospital. The authors were exempted from obtaining informed consent by the IRB because this study was a retrospective one and personal identifiers were completely removed.

Conflict of interest

The authors declare that they have no conflict of interest regarding this work.

Additional information

Beom Jin Lim and Jae Il Shin contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lim, B.J., Shin, J.I., Choi, Se. et al. The significance of tubulointerstitial lesions in childhood Henoch–Schönlein nephritis. Pediatr Nephrol 31, 2087–2093 (2016). https://doi.org/10.1007/s00467-016-3417-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-016-3417-2

Key words

Navigation